| Net loss | -3.91M |
| Depreciation and amortization | |
| Stock-based compensation expense | 868K |
| Deferred income tax benefit | |
| Change in allowance for notes and accounts receivable | |
| Other | 112K |
| Accounts receivable, current and long-term | |
| Inventories | -426K |
| Prepaid expenses and other current assets | 3.81M |
| Deferred revenue | 319K |
| Accounts payable | 667K |
| Accrued expenses | -880K |
| Net cash used in operating activities | 634K |
| Purchase of property and equipment | -226K |
| Purchase of property and equipment held under operating leases | |
| Purchase of short-term investments | |
| Proceeds from asset sales | 2.6M |
| Additions to patents and licenses | -213K |
| Long term investments | |
| Net cash used in investing activities | 2.16M |
| Payment of long-term debt | -743K |
| Proceeds from debt | |
| Proceeds from repayment of shareholders notes | |
| Excess tax benefits from stock-based compensation | |
| Deferred financing costs | |
| Proceeds from issuance of common stock | |
| Net cash provided by (used in) financing activities | 397K |
| Net (decrease) increase in cash and cash equivalents | 3.19M |
| Cash and cash equivalents at beginning of period | 15.54M |
| Cash and cash equivalents at end of period | 18.73M |
| Cash paid for interest | |
| Cash paid for income taxes | |
| Shares surrendered into treasury from stock option exercise | |
| Shares issued from treasury for stock note receivable | |